Cargando…
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET
Drug repurposing is a versatile strategy to improve current therapies. Disulfiram has long been used in the treatment of alcohol dependency and multiple clinical trials to evaluate its clinical value in oncology are ongoing. We have recently reported that the disulfiram metabolite diethyldithiocarba...
Autores principales: | Kanellis, Dimitris C., Zisi, Asimina, Skrott, Zdenek, Lemmens, Bennie, Espinoza, Jaime A., Kosar, Martin, Björkman, Andrea, Li, Xuexin, Arampatzis, Stefanos, Bartkova, Jirina, Andújar-Sánchez, Miguel, Fernandez-Capetillo, Oscar, Mistrik, Martin, Lindström, Mikael S., Bartek, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307793/ https://www.ncbi.nlm.nih.gov/pubmed/37142656 http://dx.doi.org/10.1038/s41418-023-01167-4 |
Ejemplares similares
-
Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET
por: Buchtova, Tereza, et al.
Publicado: (2021) -
The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output
por: Kanellis, Dimitris C., et al.
Publicado: (2021) -
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
por: Zisi, Asimina, et al.
Publicado: (2022) -
Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth
por: Zisi, Asimina, et al.
Publicado: (2022) -
Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
por: Majera, Dusana, et al.
Publicado: (2020)